Another study conducted by our team on gliomas revealed that the histones corresponding to the sequences -1527bp~-1338bp and -621bp~-351bp on the PTEN promoter are the two main modification sites targeted by EZH2 (data unpublished). The gene discussed is EZH2; the disease is central nervous system cancer.